118418,1,Admission,O
118418,1,Date,O
118418,1,:,O
118418,1,[,O
118418,1,**2178-1-20**,O
118418,1,],O
118418,1,Discharge,O
118418,1,Date,O
118418,1,:,O
118418,1,[,O
118418,1,**2178-2-7**,O
118418,1,],O
118418,1,Date,O
118418,1,of,O
118418,1,Birth,O
118418,1,:,O
118418,1,[,O
118418,1,**2107-2-15**,O
118418,1,],O
118418,1,Sex,O
118418,1,:,O
118418,1,M,O
118418,1,Service,O
118418,1,:,O
118418,1,OME,O
118418,1,HISTORY,O
118418,1,OF,O
118418,1,PRESENT,O
118418,1,ILLNESS,O
118418,1,:,O
118418,1,This,O
118418,1,patient,O
118418,1,is,O
118418,1,a,O
118418,1,70-year-old,O
118418,1,male,O
118418,1,with,O
118418,1,extensive,O
118418,1,locally,O
118418,1,recurrent,O
118418,1,melanoma,B-Reason
118418,1,involving,O
118418,1,his,O
118418,1,face,O
118418,1,",",O
118418,1,status,O
118418,1,post,O
118418,1,excision,O
118418,1,",",O
118418,1,neck,O
118418,1,dissection,O
118418,1,and,O
118418,1,radiation,O
118418,1,therapy,O
118418,1,.,O
118418,1,Initial,O
118418,1,staging,O
118418,1,was,O
118418,1,consistent,O
118418,1,with,O
118418,1,stage,O
118418,1,III,O
118418,1,C,O
118418,1,disease,O
118418,1,but,O
118418,1,now,O
118418,1,with,O
118418,1,mets,O
118418,1,to,O
118418,1,the,O
118418,1,lung,O
118418,1,",",O
118418,1,bone,O
118418,1,and,O
118418,1,soft,O
118418,1,tissue,O
118418,1,.,O
118418,1,He,O
118418,1,was,O
118418,1,due,O
118418,1,to,O
118418,1,be,O
118418,1,started,O
118418,1,on,O
118418,1,high-dose,O
118418,1,IL-2,B-Drug
118418,1,but,O
118418,1,in,O
118418,1,clinic,O
118418,1,on,O
118418,1,[,O
118418,1,**2178-1-12**,O
118418,1,],O
118418,1,",",O
118418,1,he,O
118418,1,was,O
118418,1,noticed,O
118418,1,to,O
118418,1,have,O
118418,1,erythema,O
118418,1,in,O
118418,1,an,O
118418,1,area,O
118418,1,of,O
118418,1,recent,O
118418,1,lymph,O
118418,1,node,O
118418,1,dissection,O
118418,1,felt,O
118418,1,consistent,O
118418,1,with,O
118418,1,cellulitis,B-Reason
118418,1,",",O
118418,1,and,O
118418,1,was,O
118418,1,started,O
118418,1,on,O
118418,1,oral,O
118418,1,Keflex,B-Drug
118418,1,",",O
118418,1,and,O
118418,1,now,O
118418,1,is,O
118418,1,presenting,O
118418,1,with,O
118418,1,worsening,O
118418,1,erythema,O
118418,1,.,O
118418,1,The,O
118418,1,patient,O
118418,1,reports,O
118418,1,that,O
118418,1,in,O
118418,1,the,O
118418,1,week,O
118418,1,since,O
118418,1,he,O
118418,1,started,O
118418,1,antibiotics,B-Drug
118418,1,",",O
118418,1,the,O
118418,1,erythema,O
118418,1,has,O
118418,1,enlarged,O
118418,1,and,O
118418,1,become,O
118418,1,more,O
118418,1,red,O
118418,1,.,O
118418,1,In,O
118418,1,clinic,O
118418,1,today,O
118418,1,",",O
118418,1,his,O
118418,1,white,O
118418,1,blood,O
118418,1,cell,O
118418,1,count,O
118418,1,was,O
118418,1,up,O
118418,1,to,O
118418,1,"20,000",O
118418,1,and,O
118418,1,he,O
118418,1,was,O
118418,1,admitted,O
118418,1,to,O
118418,1,OMED,O
118418,1,service,O
118418,1,.,O
118418,1,PAST,O
118418,1,MEDICAL,O
118418,1,HISTORY,O
118418,1,:,O
118418,1,Hypertension,O
118418,1,",",O
118418,1,metastatic,O
118418,1,melanoma,O
118418,1,with,O
118418,1,original,O
118418,1,diagnosis,O
118418,1,in,O
118418,1,[,O
118418,1,**2177-6-5**,O
118418,1,],O
118418,1,.,O
118418,1,On,O
118418,1,[,O
118418,1,**2177-8-21**,O
118418,1,],O
118418,1,he,O
118418,1,underwent,O
118418,1,wide,O
118418,1,local,O
118418,1,excision,O
118418,1,and,O
118418,1,sentinel,O
118418,1,lymph,O
118418,1,node,O
118418,1,biopsy,O
118418,1,",",O
118418,1,with,O
118418,1,melanoma,O
118418,1,present,O
118418,1,in,O
118418,1,1,O
118418,1,left,O
118418,1,intraparotid,O
118418,1,node,O
118418,1,.,O
118418,1,On,O
118418,1,[,O
118418,1,**2177-8-28**,O
118418,1,],O
118418,1,he,O
118418,1,had,O
118418,1,re-excision,O
118418,1,of,O
118418,1,the,O
118418,1,left,O
118418,1,temple,O
118418,1,and,O
118418,1,cheek,O
118418,1,area,O
118418,1,and,O
118418,1,a,O
118418,1,left,O
118418,1,radical,O
118418,1,neck,O
118418,1,dissection,O
118418,1,",",O
118418,1,with,O
118418,1,melanoma,O
118418,1,in,O
118418,1,7,O
118418,1,of,O
118418,1,69,O
118418,1,total,O
118418,1,lymph,O
118418,1,nodes,O
118418,1,.,O
118418,1,He,O
118418,1,underwent,O
118418,1,radiation,O
118418,1,therapy,O
118418,1,to,O
118418,1,the,O
118418,1,forehead,O
118418,1,area,O
118418,1,",",O
118418,1,completing,O
118418,1,20,O
118418,1,fractions,O
118418,1,over,O
118418,1,4,O
118418,1,weeks,O
118418,1,.,O
118418,1,He,O
118418,1,then,O
118418,1,developed,O
118418,1,soft,O
118418,1,tissue,O
118418,1,nodule,O
118418,1,superior,O
118418,1,to,O
118418,1,the,O
118418,1,graft,O
118418,1,",",O
118418,1,that,O
118418,1,might,O
118418,1,have,O
118418,1,represented,O
118418,1,residual,O
118418,1,melanoma,O
118418,1,and,O
118418,1,appeared,O
118418,1,to,O
118418,1,have,O
118418,1,reduced,O
118418,1,in,O
118418,1,size,O
118418,1,with,O
118418,1,radiation,O
118418,1,.,O
118418,1,In,O
118418,1,late,O
118418,1,[,O
118418,1,**2177-10-6**,O
118418,1,],O
118418,1,a,O
118418,1,PET,O
118418,1,CT,O
118418,1,showed,O
118418,1,increased,O
118418,1,glucose,O
118418,1,uptake,O
118418,1,at,O
118418,1,sites,O
118418,1,of,O
118418,1,surgery,O
118418,2,on,O
118418,2,his,O
118418,2,thigh,O
118418,2,and,O
118418,2,around,O
118418,2,the,O
118418,2,superior,O
118418,2,edge,O
118418,2,of,O
118418,2,the,O
118418,2,graft,O
118418,2,on,O
118418,2,his,O
118418,2,face,O
118418,2,.,O
118418,2,He,O
118418,2,was,O
118418,2,seen,O
118418,2,in,O
118418,2,follow-up,O
118418,2,one,O
118418,2,of,O
118418,2,three,O
118418,2,weeks,O
118418,2,after,O
118418,2,completion,O
118418,2,of,O
118418,2,radiation,O
118418,2,.,O
118418,2,Follow,O
118418,2,up,O
118418,2,head,O
118418,2,MRI,O
118418,2,and,O
118418,2,torso,O
118418,2,CT,O
118418,2,on,O
118418,2,[,O
118418,2,**2178-1-7**,O
118418,2,],O
118418,2,revealed,O
118418,2,no,O
118418,2,metastatic,O
118418,2,brain,O
118418,2,lesions,O
118418,2,",",O
118418,2,but,O
118418,2,metastatic,O
118418,2,disease,O
118418,2,in,O
118418,2,his,O
118418,2,chest,O
118418,2,",",O
118418,2,left,O
118418,2,axilla,O
118418,2,",",O
118418,2,mediastinum,O
118418,2,and,O
118418,2,lung,O
118418,2,",",O
118418,2,as,O
118418,2,well,O
118418,2,as,O
118418,2,a,O
118418,2,T12,O
118418,2,sclerotic,O
118418,2,focus,O
118418,2,felt,O
118418,2,consistent,O
118418,2,with,O
118418,2,melanoma,B-Reason
118418,2,.,O
118418,2,The,O
118418,2,BRCA,O
118418,2,mutation,O
118418,2,testing,O
118418,2,on,O
118418,2,his,O
118418,2,tumor,O
118418,2,was,O
118418,2,negative,O
118418,2,.,O
118418,2,He,O
118418,2,has,O
118418,2,passed,O
118418,2,screening,O
118418,2,tests,O
118418,2,to,O
118418,2,begin,O
118418,2,high-dose,O
118418,2,IL-2,B-Drug
118418,2,therapy,O
118418,2,.,O
118418,2,ALLERGIES,O
118418,2,:,O
118418,2,No,O
118418,2,known,O
118418,2,drug,O
118418,2,allergies,O
118418,2,.,O
118418,2,MEDICATIONS,O
118418,2,ON,O
118418,2,ADMISSION,O
118418,2,:,O
118418,2,Enalapril,B-Drug
118418,2,20,O
118418,2,mg,O
118418,2,p.o,O
118418,2,.,O
118418,2,daily,O
118418,2,",",O
118418,2,pravastatin,B-Drug
118418,2,20,O
118418,2,mg,O
118418,2,p.o,O
118418,2,.,O
118418,2,daily,O
118418,2,",",O
118418,2,Keflex,B-Drug
118418,2,500,O
118418,2,mg,O
118418,2,p.o,O
118418,2,.,O
118418,2,b.i.d,O
118418,2,.,O
118418,2,PHYSICAL,O
118418,2,EXAMINATION,O
118418,2,ON,O
118418,2,ADMISSION,O
118418,2,:,O
118418,2,Reveals,O
118418,2,an,O
118418,2,elderly,O
118418,2,male,O
118418,2,in,O
118418,2,no,O
118418,2,apparent,O
118418,2,distress,O
118418,2,.,O
118418,2,HEENT,O
118418,2,:,O
118418,2,Pupils,O
118418,2,equal,O
118418,2,",",O
118418,2,round,O
118418,2,",",O
118418,2,reactive,O
118418,2,to,O
118418,2,light,O
118418,2,.,O
118418,2,Left,O
118418,2,temporal,O
118418,2,and,O
118418,2,buccal,O
118418,2,graft,O
118418,2,without,O
118418,2,erythema,O
118418,2,.,O
118418,2,NECK,O
118418,2,:,O
118418,2,Well-healed,O
118418,2,scar,O
118418,2,from,O
118418,2,posterior,O
118418,2,auricular,O
118418,2,area,O
118418,2,to,O
118418,2,the,O
118418,2,left,O
118418,2,upper,O
118418,2,chest,O
118418,2,.,O
118418,2,No,O
118418,2,signs,O
118418,2,of,O
118418,2,wound,O
118418,2,dehiscence,O
118418,2,.,O
118418,2,Broad,O
118418,2,area,O
118418,2,of,O
118418,2,erythema,O
118418,2,and,O
118418,2,corresponding,O
118418,2,area,O
118418,2,warm,O
118418,2,to,O
118418,2,touch,O
118418,2,.,O
118418,2,No,O
118418,2,palpable,O
118418,2,masses,O
118418,2,or,O
118418,2,fluid,O
118418,2,collections,O
118418,2,.,O
118418,2,No,O
118418,2,cervical,O
118418,2,",",O
118418,2,supraclavicular,O
118418,2,or,O
118418,2,axillary,O
118418,2,lymphadenopathy,O
118418,2,.,O
118418,2,HEART,O
118418,2,:,O
118418,2,Regular,O
118418,2,rate,O
118418,2,and,O
118418,2,rhythm,O
118418,2,",",O
118418,2,S1,O
118418,2,",",O
118418,2,S2,O
118418,2,.,O
118418,2,CHEST,O
118418,2,:,O
118418,2,No,O
118418,2,dullness,O
118418,2,to,O
118418,2,percussion,O
118418,2,and,O
118418,2,clear,O
118418,2,to,O
118418,2,auscultation,O
118418,2,bilaterally,O
118418,2,.,O
118418,2,ABDOMEN,O
118418,2,:,O
118418,2,Positive,O
118418,2,bowel,O
118418,2,sounds,O
118418,2,",",O
118418,2,soft,O
118418,2,",",O
118418,2,nontender,O
118418,2,.,O
118418,2,EXTREMITIES,O
118418,2,:,O
118418,2,Warm,O
118418,2,and,O
118418,2,well,O
118418,2,perfused,O
118418,2,",",O
118418,2,1+,O
118418,2,edema,O
118418,2,to,O
118418,2,[,O
118418,2,**12-8**,O
118418,2,],O
118418,2,the,O
118418,2,way,O
118418,2,up,O
118418,2,shins,O
118418,2,bilaterally,O
118418,2,",",O
118418,2,2+,O
118418,2,DP,O
118418,2,and,O
118418,2,PT,O
118418,2,pulses,O
118418,2,.,O
118418,2,NEUROLOGIC,O
118418,2,EXAM,O
118418,2,:,O
118418,2,Nonfocal,O
118418,2,.,O
118418,2,ADMISSION,O
118418,2,LABS,O
118418,2,:,O
118418,2,WBC,O
118418,2,20.9,O
118418,2,",",O
118418,2,hemoglobin,O
118418,2,11.7,O
118418,2,",",O
118418,2,hematocrit,O
118418,2,33.7,O
118418,2,",",O
118418,2,platelet,O
118418,2,count,O
118418,2,"206,000",O
118418,2,",",O
118418,2,BUN,O
118418,2,20,O
118418,2,",",O
118418,2,creatinine,O
118418,2,1.2,O
118418,2,",",O
118418,2,sodium,O
118418,2,134,O
118418,2,",",O
118418,2,potassium,O
118418,2,6.1,O
118418,2,",",O
118418,2,chloride,O
118418,2,101,O
118418,2,",",O
118418,2,CO2,O
118418,2,23,O
118418,3,",",O
118418,3,glucose,O
118418,3,117,O
118418,3,.,O
118418,3,HOSPITAL,O
118418,3,COURSE,O
118418,3,:,O
118418,3,The,O
118418,3,patient,O
118418,3,was,O
118418,3,admitted,O
118418,3,with,O
118418,3,cellulitis,B-Reason
118418,3,and,O
118418,3,was,O
118418,3,placed,O
118418,3,on,O
118418,3,IV,O
118418,3,vancomycin,B-Drug
118418,3,.,O
118418,3,Doxycycline,B-Drug
118418,3,was,O
118418,3,added,O
118418,3,when,O
118418,3,he,O
118418,3,did,O
118418,3,not,O
118418,3,appear,O
118418,3,to,O
118418,3,be,O
118418,3,improving,O
118418,3,.,O
118418,3,Unasyn,B-Drug
118418,3,was,O
118418,3,added,O
118418,3,when,O
118418,3,the,O
118418,3,cellulitic,B-Reason
118418,3,area,I-Reason
118418,3,continued,I-Reason
118418,3,to,I-Reason
118418,3,worsen,I-Reason
118418,3,.,O
118418,3,He,O
118418,3,also,O
118418,3,became,O
118418,3,short,B-Reason
118418,3,of,I-Reason
118418,3,breath,I-Reason
118418,3,and,O
118418,3,was,O
118418,3,treated,O
118418,3,with,O
118418,3,Lasix,B-Drug
118418,3,.,O
118418,3,Transthoracic,O
118418,3,echo,O
118418,3,revealed,O
118418,3,diastolic,B-Reason
118418,3,heart,I-Reason
118418,3,failure,I-Reason
118418,3,and,O
118418,3,he,O
118418,3,was,O
118418,3,continued,O
118418,3,on,O
118418,3,enalapril,B-Drug
118418,3,and,O
118418,3,Lasix,B-Drug
118418,3,.,O
118418,3,He,O
118418,3,had,O
118418,3,an,O
118418,3,ID,O
118418,3,consult,O
118418,3,on,O
118418,3,[,O
118418,3,**1-28**,O
118418,3,],O
118418,3,who,O
118418,3,suggested,O
118418,3,stopping,O
118418,3,the,O
118418,3,Unasyn,B-Drug
118418,3,",",O
118418,3,changing,O
118418,3,to,O
118418,3,cefepime,B-Drug
118418,3,and,O
118418,3,adding,O
118418,3,vancomycin,B-Drug
118418,3,back,O
118418,3,.,O
118418,3,Blood,O
118418,3,cultures,O
118418,3,remained,O
118418,3,negative,O
118418,3,and,O
118418,3,he,O
118418,3,was,O
118418,3,afebrile,O
118418,3,throughout,O
118418,3,this,O
118418,3,time,O
118418,3,.,O
118418,3,Derm,O
118418,3,consult,O
118418,3,on,O
118418,3,[,O
118418,3,**1-28**,O
118418,3,],O
118418,3,was,O
118418,3,obtained,O
118418,3,due,O
118418,3,to,O
118418,3,persistent,O
118418,3,rash,O
118418,3,",",O
118418,3,and,O
118418,3,a,O
118418,3,biopsy,O
118418,3,was,O
118418,3,performed,O
118418,3,consistent,O
118418,3,with,O
118418,3,melanoma,B-Reason
118418,3,.,O
118418,3,He,O
118418,3,was,O
118418,3,subsequently,O
118418,3,transferred,O
118418,3,to,O
118418,3,the,O
118418,3,biologic,O
118418,3,service,O
118418,3,on,O
118418,3,[,O
118418,3,**2178-1-30**,O
118418,3,],O
118418,3,to,O
118418,3,begin,O
118418,3,high-dose,O
118418,3,IL-2,B-Drug
118418,3,therapy,O
118418,3,.,O
118418,3,During,O
118418,3,this,O
118418,3,week,O
118418,3,he,O
118418,3,received,O
118418,3,7,O
118418,3,of,O
118418,3,14,O
118418,3,doses,O
118418,3,with,O
118418,3,7,O
118418,3,doses,O
118418,3,held,O
118418,3,related,O
118418,3,to,O
118418,3,tachycardia,B-ADE
118418,3,and,O
118418,3,pulmonary,B-Reason
118418,3,edema,I-Reason
118418,3,.,O
118418,3,On,O
118418,3,treatment,O
118418,3,day,O
118418,3,#,O
118418,3,4,O
118418,3,",",O
118418,3,he,O
118418,3,was,O
118418,3,tachypneic,O
118418,3,with,O
118418,3,hypoxia,O
118418,3,to,O
118418,3,the,O
118418,3,mid,O
118418,3,80s,O
118418,3,.,O
118418,3,Chest,O
118418,3,x-,O
118418,3,ray,O
118418,3,was,O
118418,3,consistent,O
118418,3,with,O
118418,3,bilateral,B-Reason
118418,3,pleural,I-Reason
118418,3,effusions,I-Reason
118418,3,.,O
118418,3,Throughout,O
118418,3,the,O
118418,3,day,O
118418,3,he,O
118418,3,became,O
118418,3,increasingly,O
118418,3,more,O
118418,3,tachypneic,B-Reason
118418,3,and,O
118418,3,fatigued,B-Reason
118418,3,",",O
118418,3,and,O
118418,3,was,O
118418,3,transferred,O
118418,3,to,O
118418,3,the,O
118418,3,ICU,O
118418,3,.,O
118418,3,He,O
118418,3,was,O
118418,3,treated,O
118418,3,with,O
118418,3,Lasix,B-Drug
118418,3,with,O
118418,3,improvement,O
118418,3,in,O
118418,3,his,O
118418,3,respiratory,O
118418,3,status,O
118418,3,.,O
118418,3,An,O
118418,3,echocardiogram,O
118418,3,on,O
118418,3,[,O
118418,3,**2178-2-3**,O
118418,3,],O
118418,3,showed,O
118418,3,a,O
118418,3,small,O
118418,3,pericardial,O
118418,3,effusion,O
118418,3,with,O
118418,3,question,O
118418,3,tamponade,O
118418,3,physiology,O
118418,3,.,O
118418,3,Cardiology,O
118418,3,was,O
118418,3,consulted,O
118418,3,and,O
118418,3,felt,O
118418,3,they,O
118418,3,were,O
118418,3,not,O
118418,3,able,O
118418,3,to,O
118418,3,tap,O
118418,3,the,O
118418,3,effusion,O
118418,3,.,O
118418,3,He,O
118418,3,underwent,O
118418,3,a,O
118418,3,cardiac,O
118418,3,MRI,O
118418,3,on,O
118418,3,[,O
118418,3,**2178-2-4**,O
118418,3,],O
118418,3,revealing,O
118418,3,no,O
118418,3,cardiac,O
118418,3,metastases,O
118418,3,and,O
118418,3,no,O
118418,3,tamponade,O
118418,3,physiology,O
118418,3,.,O
118418,3,He,O
118418,3,developed,O
118418,3,SVT,B-Reason
118418,3,to,O
118418,3,the,O
118418,3,140s,O
118418,3,on,O
118418,3,[,O
118418,3,**2178-2-4**,O
118418,3,],O
118418,3,",",O
118418,3,which,O
118418,3,spontaneously,O
118418,3,improved,O
118418,3,with,O
118418,3,a,O
118418,3,fluid,B-Drug
118418,3,bolus,O
118418,3,.,O
118418,3,His,O
118418,3,respiratory,O
118418,3,status,O
118418,3,improved,O
118418,3,with,O
118418,3,continued,O
118418,3,diuresis,B-Reason
118418,3,",",O
118418,3,and,O
118418,3,he,O
118418,3,was,O
118418,3,transferred,O
118418,4,back,O
118418,4,to,O
118418,4,the,O
118418,4,floor,O
118418,4,on,O
118418,4,[,O
118418,4,**2178-2-5**,O
118418,4,],O
118418,4,.,O
118418,4,Lasix,B-Drug
118418,4,and,O
118418,4,enalapril,B-Drug
118418,4,were,O
118418,4,continued,O
118418,4,and,O
118418,4,he,O
118418,4,was,O
118418,4,weaned,O
118418,4,to,O
118418,4,room,O
118418,4,air,O
118418,4,with,O
118418,4,O2,O
118418,4,saturations,O
118418,4,in,O
118418,4,the,O
118418,4,mid,O
118418,4,90s,O
118418,4,.,O
118418,4,Physical,O
118418,4,therapy,O
118418,4,consult,O
118418,4,was,O
118418,4,initiated,O
118418,4,and,O
118418,4,he,O
118418,4,was,O
118418,4,ambulating,O
118418,4,short,O
118418,4,distances,O
118418,4,with,O
118418,4,a,O
118418,4,steady,O
118418,4,gait,O
118418,4,.,O
118418,4,He,O
118418,4,was,O
118418,4,discharged,O
118418,4,to,O
118418,4,home,O
118418,4,on,O
118418,4,[,O
118418,4,**2178-2-7**,O
118418,4,],O
118418,4,with,O
118418,4,a,O
118418,4,plan,O
118418,4,to,O
118418,4,follow,O
118418,4,up,O
118418,4,in,O
118418,4,clinic,O
118418,4,on,O
118418,4,[,O
118418,4,**2178-2-10**,O
118418,4,],O
118418,4,.,O
118418,4,Other,O
118418,4,side,O
118418,4,effects,O
118418,4,related,O
118418,4,to,O
118418,4,IL-2,B-Drug
118418,4,included,O
118418,4,rigors,B-Reason
118418,4,improved,O
118418,4,with,O
118418,4,Demerol,B-Drug
118418,4,;,O
118418,4,fatigue,B-ADE
118418,4,;,O
118418,4,and,O
118418,4,hypotension,B-Reason
118418,4,on,O
118418,4,treatment,O
118418,4,day,O
118418,4,3,O
118418,4,",",O
118418,4,requiring,O
118418,4,fluid,B-Drug
118418,4,boluses,O
118418,4,.,O
118418,4,During,O
118418,4,this,O
118418,4,week,O
118418,4,he,O
118418,4,developed,O
118418,4,acute,O
118418,4,renal,O
118418,4,failure,O
118418,4,with,O
118418,4,a,O
118418,4,peak,O
118418,4,creatinine,O
118418,4,of,O
118418,4,3.0,O
118418,4,with,O
118418,4,associated,O
118418,4,oliguria,O
118418,4,.,O
118418,4,He,O
118418,4,developed,O
118418,4,metabolic,B-Reason
118418,4,acidosis,I-Reason
118418,4,with,O
118418,4,a,O
118418,4,minimum,O
118418,4,bicarb,O
118418,4,of,O
118418,4,18,O
118418,4,",",O
118418,4,improved,O
118418,4,with,O
118418,4,bicarbonate,B-Drug
118418,4,boluses,O
118418,4,.,O
118418,4,Electrolytes,O
118418,4,were,O
118418,4,monitored,O
118418,4,and,O
118418,4,repleted,O
118418,4,per,O
118418,4,protocol,O
118418,4,.,O
118418,4,Strict,O
118418,4,I,O
118418,4,&,O
118418,4,Os,O
118418,4,and,O
118418,4,serum,O
118418,4,chemistries,O
118418,4,were,O
118418,4,maintained,O
118418,4,.,O
118418,4,IV,O
118418,4,fluids,B-Drug
118418,4,were,O
118418,4,continued,O
118418,4,given,O
118418,4,acute,O
118418,4,renal,O
118418,4,failure,O
118418,4,.,O
118418,4,During,O
118418,4,this,O
118418,4,week,O
118418,4,he,O
118418,4,had,O
118418,4,mild,O
118418,4,ST,O
118418,4,elevation,O
118418,4,to,O
118418,4,54,O
118418,4,",",O
118418,4,which,O
118418,4,improved,O
118418,4,prior,O
118418,4,to,O
118418,4,discharge,O
118418,4,.,O
118418,4,He,O
118418,4,had,O
118418,4,no,O
118418,4,hyperbilirubinemia,O
118418,4,",",O
118418,4,myocarditis,O
118418,4,or,O
118418,4,coagulopathy,O
118418,4,noted,O
118418,4,.,O
118418,4,He,O
118418,4,was,O
118418,4,thrombocytopenic,O
118418,4,to,O
118418,4,a,O
118418,4,platelet,O
118418,4,count,O
118418,4,low,O
118418,4,of,O
118418,4,"68,000",O
118418,4,without,O
118418,4,evidence,O
118418,4,of,O
118418,4,bleeding,O
118418,4,.,O
118418,4,He,O
118418,4,was,O
118418,4,anemic,O
118418,4,and,O
118418,4,was,O
118418,4,transfused,O
118418,4,with,O
118418,4,packed,O
118418,4,red,O
118418,4,blood,O
118418,4,cells,O
118418,4,with,O
118418,4,discharge,O
118418,4,hemoglobin,O
118418,4,of,O
118418,4,9.1,O
118418,4,.,O
118418,4,By,O
118418,4,[,O
118418,4,**2178-2-7**,O
118418,4,],O
118418,4,he,O
118418,4,had,O
118418,4,recovered,O
118418,4,from,O
118418,4,side,O
118418,4,effects,O
118418,4,to,O
118418,4,allow,O
118418,4,for,O
118418,4,discharge,O
118418,4,to,O
118418,4,home,O
118418,4,.,O
118418,4,CONDITION,O
118418,4,ON,O
118418,4,DISCHARGE,O
118418,4,:,O
118418,4,Alert,O
118418,4,",",O
118418,4,oriented,O
118418,4,and,O
118418,4,ambulatory,O
118418,4,.,O
118418,4,DISCHARGE,O
118418,4,STATUS,O
118418,4,:,O
118418,4,To,O
118418,4,home,O
118418,4,with,O
118418,4,his,O
118418,4,family,O
118418,4,.,O
118418,4,DISCHARGE,O
118418,4,DIAGNOSES,O
118418,4,:,O
118418,4,1,O
118418,4,.,O
118418,4,Metastatic,B-Reason
118418,4,melanoma,I-Reason
118418,4,status,O
118418,4,post,O
118418,4,cycle,O
118418,4,1,O
118418,4,",",O
118418,4,week,O
118418,4,1,O
118418,4,",",O
118418,4,high-,O
118418,4,dose,O
118418,4,IL-2,B-Drug
118418,4,therapy,O
118418,4,complicated,O
118418,4,by,O
118418,4,pulmonary,B-ADE
118418,4,edema,I-ADE
118418,4,",",O
118418,4,and,O
118418,4,bilateral,B-ADE
118418,4,pleural,I-ADE
118418,4,effusions,I-ADE
118418,4,from,O
118418,4,IL-2,B-Drug
118418,4,induced,O
118418,4,capillary,B-ADE
118418,4,leak,I-ADE
118418,4,",",O
118418,4,with,O
118418,4,respiratory,B-ADE
118418,4,distress,I-ADE
118418,4,.,O
118418,4,2,O
118418,4,.,O
118418,4,Acute,B-ADE
118418,4,renal,I-ADE
118418,4,failure,I-ADE
118418,4,related,O
118418,4,to,O
118418,4,IL-2,B-Drug
118418,4,therapy,O
118418,4,.,O
118418,4,DISCHARGE,O
118418,4,MEDICATIONS,O
118418,4,:,O
118418,4,Enalapril,B-Drug
118418,5,20,O
118418,5,mg,O
118418,5,p.o,O
118418,5,.,O
118418,5,daily,O
118418,5,",",O
118418,5,Lasix,B-Drug
118418,5,20,O
118418,5,mg,O
118418,5,p.o,O
118418,5,.,O
118418,5,daily,O
118418,5,",",O
118418,5,lorazepam,B-Drug
118418,5,0.5,O
118418,5,mg,O
118418,5,q,O
118418,5,.,O
118418,5,6,O
118418,5,hours,O
118418,5,p.r.n,O
118418,5,.,O
118418,5,nausea,B-Reason
118418,5,",",O
118418,5,pravastatin,B-Drug
118418,5,20,O
118418,5,mg,O
118418,5,p.o,O
118418,5,.,O
118418,5,daily,O
118418,5,",",O
118418,5,Compazine,B-Drug
118418,5,5,O
118418,5,to,O
118418,5,10,O
118418,5,mg,O
118418,5,q.i.d,O
118418,5,.,O
118418,5,p.r.n,O
118418,5,.,O
118418,5,nausea,B-Reason
118418,5,.,O
118418,5,FOLLOW-UP,O
118418,5,PLANS,O
118418,5,:,O
118418,5,The,O
118418,5,patient,O
118418,5,will,O
118418,5,return,O
118418,5,to,O
118418,5,clinic,O
118418,5,on,O
118418,5,[,O
118418,5,**2178-2-10**,O
118418,5,],O
118418,5,for,O
118418,5,assessment,O
118418,5,of,O
118418,5,his,O
118418,5,clinical,O
118418,5,status,O
118418,5,prior,O
118418,5,to,O
118418,5,consideration,O
118418,5,for,O
118418,5,treatment,O
118418,5,with,O
118418,5,week,O
118418,5,#,O
118418,5,2,O
118418,5,of,O
118418,5,therapy,O
118418,5,.,O
118418,5,I,O
118418,5,have,O
118418,5,reviewed,O
118418,5,the,O
118418,5,discharge,O
118418,5,summary,O
118418,5,and,O
118418,5,agree,O
118418,5,with,O
118418,5,the,O
118418,5,hospital,O
118418,5,course,O
118418,5,and,O
118418,5,disposition,O
118418,5,as,O
118418,5,dictated,O
118418,5,by,O
118418,5,[,O
118418,5,**First,O
118418,5,Name8,O
118418,5,(,O
118418,5,NamePattern2,O
118418,5,),O
118418,5,622**,O
118418,5,],O
118418,5,[,O
118418,5,**Last,O
118418,5,Name,O
118418,5,(,O
118418,5,NamePattern1,O
118418,5,),O
118418,5,17265**,O
118418,5,],O
118418,5,.,O
118418,5,[,O
118418,5,**First,O
118418,5,Name11,O
118418,5,(,O
118418,5,Name,O
118418,5,Pattern1,O
118418,5,),O
118418,5,**,O
118418,5,],O
118418,5,[,O
118418,5,**Last,O
118418,5,Name,O
118418,5,(,O
118418,5,NamePattern1,O
118418,5,),O
118418,5,**,O
118418,5,],O
118418,5,",",O
118418,5,MD,O
118418,5,[,O
118418,5,**MD,O
118418,5,Number,O
118418,5,(,O
118418,5,2,O
118418,5,),O
118418,5,66804**,O
118418,5,],O
118418,5,Dictated,O
118418,5,By,O
118418,5,:,O
118418,5,[,O
118418,5,**Last,O
118418,5,Name,O
118418,5,(,O
118418,5,NamePattern1,O
118418,5,),O
118418,5,18853**,O
118418,5,],O
118418,5,MEDQUIST36,O
118418,5,D,O
118418,5,:,O
118418,5,[,O
118418,5,**2178-2-24**,O
118418,5,],O
118418,5,12:32:55,O
118418,5,T,O
118418,5,:,O
118418,5,[,O
118418,5,**2178-2-25**,O
118418,5,],O
118418,5,15:33:12,O
118418,5,Job,O
118418,5,#,O
118418,5,:,O
118418,5,[,O
118418,5,**Job,O
118418,5,Number,O
118418,5,87177**,O
118418,5,],O
118418,5,cc,O
118418,5,:,O
118418,5,[,O
118418,5,**Numeric,O
118418,5,Identifier,O
118418,5,87178**,O
118418,5,],O
